- Prof. D. Olivieri who was our guest speaker gave a presentation on “Immunology of COPD exacerbations and role of immunomodulators” , he highlighted on Lung immune defense mechanisms in healthy subjects and COPD patient.
- Also, Clinical relevance of exacerbations in COPD, Microbiome and microbial-host relationships in the lung were also discussed.
- Rationale for the prevention of COPD exacerbations by Broncho-Vaxom: experimental data & clinical studies.
- He presented Broncho-Vaxom recent clinical studies (Soler 2007, Li 2004, Collet 1997, Orcel 1994, Tang 2015) and its impact on the reduction of COPD exacerbations.
- Recommendation of Broncho-Vaxom in EPOS 2012 guidelines to be GRADE: A hence, there is a strong relation between the nose and the lungs. As well as, Broncho-Vaxom Safety profile and Recent Abstract on Broncho-Vaxom in COPD; systematic review and meta-analysis.